BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30885951)

  • 1. Variation in the Plasma Membrane Monoamine Transporter (PMAT) (Encoded by
    Dawed AY; Zhou K; van Leeuwen N; Mahajan A; Robertson N; Koivula R; Elders PJM; Rauh SP; Jones AG; Holl RW; Stingl JC; Franks PW; McCarthy MI; 't Hart LM; Pearson ER;
    Diabetes Care; 2019 Jun; 42(6):1027-1033. PubMed ID: 30885951
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu Z; Jia X; Wu P; Wu B; Pan Y; Zhong S; Xiao L; Song Y; Hu J; Zhou K
    Pharmacogenomics; 2023 Jul; 24(10):551-560. PubMed ID: 37458617
    [No Abstract]   [Full Text] [Related]  

  • 3. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.
    Dujic T; Causevic A; Bego T; Malenica M; Velija-Asimi Z; Pearson ER; Semiz S
    Diabet Med; 2016 Apr; 33(4):511-4. PubMed ID: 26605869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study.
    Dujic T; Zhou K; Tavendale R; Palmer CN; Pearson ER
    Diabetes Care; 2016 Nov; 39(11):1896-1901. PubMed ID: 27493135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study.
    Dujic T; Zhou K; Donnelly LA; Tavendale R; Palmer CN; Pearson ER
    Diabetes; 2015 May; 64(5):1786-93. PubMed ID: 25510240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
    Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
    Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09).
    Joerger M; van Schaik RH; Becker ML; Hayoz S; Pollak M; Cathomas R; Winterhalder R; Gillessen S; Rothermundt C
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):167-72. PubMed ID: 25753371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
    Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
    Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function.
    Chen L; Takizawa M; Chen E; Schlessinger A; Segenthelar J; Choi JH; Sali A; Kubo M; Nakamura S; Iwamoto Y; Iwasaki N; Giacomini KM
    J Pharmacol Exp Ther; 2010 Oct; 335(1):42-50. PubMed ID: 20639304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine.
    Zhou M; Xia L; Wang J
    Drug Metab Dispos; 2007 Oct; 35(10):1956-62. PubMed ID: 17600084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin transporter pharmacogenomics: insights into drug disposition-where are we now?
    Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1149-1159. PubMed ID: 30375241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis.
    Peng A; Gong C; Xu Y; Liang X; Chen X; Hong W; Yan J
    Front Public Health; 2023; 11():1183879. PubMed ID: 37546319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genetics of Adverse Drug Outcomes in Type 2 Diabetes: A Systematic Review.
    Baye AM; Fanta TG; Siddiqui MK; Dawed AY
    Front Genet; 2021; 12():675053. PubMed ID: 34194474
    [No Abstract]   [Full Text] [Related]  

  • 14. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.
    Shikata E; Yamamoto R; Takane H; Shigemasa C; Ikeda T; Otsubo K; Ieiri I
    J Hum Genet; 2007; 52(2):117-122. PubMed ID: 17111267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol.
    Mato EPM; Guewo-Fokeng M; Faadiel Essop M; Owira PMO
    Syst Rev; 2018 Jul; 7(1):105. PubMed ID: 30041690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of biguanide transporters in human fat cells and their impact on lipolysis.
    Arner P; Kulyté A; Batchelor K; Laurencikiene J; Livingston J; Rydén M
    Diabetes Obes Metab; 2018 Oct; 20(10):2416-2425. PubMed ID: 29862627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study.
    Reséndiz-Abarca CA; Flores-Alfaro E; Suárez-Sánchez F; Cruz M; Valladares-Salgado A; Del Carmen Alarcón-Romero L; Vázquez-Moreno MA; Wacher-Rodarte NA; Gómez-Zamudio JH
    J Clin Pharmacol; 2019 Oct; 59(10):1384-1390. PubMed ID: 31012983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans.
    Moon SJ; Oh J; Lee SH; Choi Y; Yu KS; Chung JY
    Transl Clin Pharmacol; 2018 Jun; 26(2):79-85. PubMed ID: 32055553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.
    Han TK; Proctor WR; Costales CL; Cai H; Everett RS; Thakker DR
    J Pharmacol Exp Ther; 2015 Mar; 352(3):519-28. PubMed ID: 25563903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes.
    Kawoosa F; Shah ZA; Masoodi SR; Amin A; Rasool R; Fazili KM; Dar AH; Lone A; Ul Bashir S
    BMC Endocr Disord; 2022 May; 22(1):140. PubMed ID: 35619086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.